FIT for the early detection of colorectal cancer

FIT screening has become the method of choice for the  early detection of colorectal cancer.

Over 120 million people across 55 countries are screened using OC-Sensor every year through established national programmes. 

European guidelines* recommend quantitative FIT as the first choice test for population-wide colorectal cancer screening.

(Karsa, L. et al. Overview: European guidelines for quality assurance in CRC screening and diagnosis…Endoscopy 2013; 45: 51-59)


Detect Colorectal Cancer

Colorectal Cancer (CRC) is the fourth biggest cancer killer in the UK, with approximately 41,000 people being diagnosed each year. More than 90% of CRCs cases are treatable if detected early, but still there are more than 15,000 deaths per year (statistics from Cancer Research UK). Early detection of cancerous lesions or advanced adenomas is critical in order to administer treatment and significantly improve patient prognosis.


Colonoscopy remains the standard method to diagnose CRC. However, colonoscopy does have limitations, the uptake by patients is very low because the bowel preparation process and the procedure itself are unpleasant for patients. Colonoscopy is an invasive procedure and while minimal, is not without risk.

In most countries, available colonoscopy resource is scarce. By implementing OC-Sensor, national and regional cancer prevention schemes are able to balance population screening with local infrastructure and resources.

Stool tests for occult blood

As an alternative procedure to colonoscopy, stool tests for detecting occult blood in stools have become established. Here there is a difference between conventional chemical tests (gFOBT) and the new and significantly more conclusive immunochemical tests

Find out more about FIT

FIT-Screening with OC-Sensor

  • Simple and hygienic to use
  • Non-invasive
  • One stool sample
  • No dietary restrictions
  • Better sensitivity and specificity than gFOBT
  • Quality-assured quantitative analysis
  • Good performance evaluated in extensive clinical trials
  • The most recognised FIT screening worldwide
  • Completely fulfils all the requirements in the new guidelines for the early detection of cancer

Find out how you can help your patients with OC-Sensor